Skip to content
CTI Academy Sponsor CTI Academy
Ransomware victim Healthcare

Hangzhou Qihan Biotech Co., Ltd.

Listed by Global on · organisation based in China

www.qihanbio.com

Disclosed
Aug 28, 2026
Leak-site listing date
Threat group
Global
40 victims listed
Country
China
#28 most targeted
Sector
Healthcare

ThreatAI analysis

Compiled from this incident record and the threat intelligence profile for Global. Figures and technique mappings are quoted from the source data, not inferred.

Global listed Hangzhou Qihan Biotech Co., Ltd. on its dark web leak site on 28 August 2026. The biotech firm specializes in gene editing and cell/organ therapies to treat cancer and organ failure.

About Hangzhou Qihan Biotech Co., Ltd.

Qihan Biotech is a Hangzhou‑based biotech company specializing in gene editing and cell/organ therapies. It develops immune‑privileged cells and xenogeneic organs to treat cancer and organ failure. The company aims to make these therapies accessible worldwide.

Source record: ransomware.live

About the Global group

GLOBAL GROUP is a ransomware-as-a-service operation that emerged in June 2025, reportedly launched by a known Russian-speaking threat actor, featuring AI-driven ransom negotiation and a mobile control panel for affiliates, targeting healthcare, oil and gas, industrial engineering, and automotive sectors. Global has listed 38 victims since May 2025.

Incident analysis

Hangzhou Qihan Biotech Co., Ltd. was listed by Global ransomware, a group with 40 victims recorded in this database. The listing appeared on the group's leak site on August 28, 2026.

Hangzhou Qihan Biotech Co., Ltd. is based in China and operates in the Healthcare sector. China ranks #28 worldwide for ransomware disclosures, with 126 victims in this database.

Sector context. Healthcare organisations are high-value ransomware targets because patient data is extremely sensitive, regulatory penalties for breaches are severe, and operational downtime can threaten patient safety — all factors that increase ransom payment pressure.

Global typically follows a double extortion model: data is exfiltrated from the victim's systems before files are encrypted, so the victim faces two demands at once — pay to restore access, and pay to keep stolen data unpublished. The leak site, where this listing appeared, is the lever for the second demand.

Frequently asked questions

Was Hangzhou Qihan Biotech Co., Ltd. attacked by ransomware?

Yes. Hangzhou Qihan Biotech Co., Ltd. was listed as a victim of the Global ransomware group on August 28, 2026. The organisation is based in China and operates in the Healthcare sector. The disclosure appeared on the group's dark web leak site.

Which ransomware group attacked Hangzhou Qihan Biotech Co., Ltd.?

Hangzhou Qihan Biotech Co., Ltd. was attacked by Global ransomware. Global is one of the most active ransomware groups, having claimed 40 victims globally. The group typically employs a double-extortion model: encrypting the victim's files and threatening to publish stolen data.

When did the Hangzhou Qihan Biotech Co., Ltd. ransomware attack occur?

The ransomware attack on Hangzhou Qihan Biotech Co., Ltd. was disclosed on August 28, 2026. This date reflects when the victim was published on the threat group's leak site, which may differ from the actual date of initial compromise.

What data was stolen in the Hangzhou Qihan Biotech Co., Ltd. ransomware attack?

The specific data stolen from Hangzhou Qihan Biotech Co., Ltd. has not been independently verified by this platform. Ransomware groups typically exfiltrate data before encrypting systems and use the threat of publication to pressure victims. As a Healthcare organisation, Hangzhou Qihan Biotech Co., Ltd. likely held patient records, medical data, and personally identifiable information (PII).

How can organisations protect against Global attacks?

To defend against Global and similar threat actors, organisations should: maintain regular offline backups tested for restoration; implement network segmentation to limit lateral movement; deploy multi-factor authentication on all remote access; use endpoint detection and response (EDR) tools; conduct regular phishing and security awareness training; and monitor threat intelligence feeds for indicators of compromise (IOCs) associated with active groups.